{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:20:26Z","timestamp":1789698026297,"version":"4.0.1"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02758-3","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T06:37:17Z","timestamp":1765262237000},"page":"461-481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Who and how to screen for Cushing\u2019s syndrome: the position statement of the Italian Society of Endocrinology"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1456-8716","authenticated-orcid":false,"given":"Filippo","family":"Ceccato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4171-2851","authenticated-orcid":false,"given":"Massimo","family":"Terzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5062-9208","authenticated-orcid":false,"given":"Federico","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8779-7283","authenticated-orcid":false,"given":"Salvatore","family":"Cannav\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4896-5499","authenticated-orcid":false,"given":"Antonio","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9037-5417","authenticated-orcid":false,"given":"Andrea M.","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4049-2559","authenticated-orcid":false,"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1410-6143","authenticated-orcid":false,"given":"Diego","family":"Ferone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6186-0106","authenticated-orcid":false,"given":"Gianluca","family":"Aimaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6065-7803","authenticated-orcid":false,"given":"Francesca","family":"Pecori Giraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6204-3423","authenticated-orcid":false,"given":"Giorgio","family":"Arnaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9396-3815","authenticated-orcid":false,"given":"Carla","family":"Scaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"9","key":"2758_CR1","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1210\/jc.2009-0612","volume":"94","author":"M Boscaro","year":"2009","unstructured":"Boscaro M, Arnaldi G (2009) Approach to the patient with possible Cushing\u2019s syndrome. J Clin Endocrinol Metab 94(9):3121\u20133131. https:\/\/doi.org\/10.1210\/jc.2009-0612","journal-title":"J Clin Endocrinol Metab"},{"issue":"10418","key":"2758_CR2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","volume":"402","author":"M Gadelha","year":"2023","unstructured":"Gadelha M, Gatto F, Wildemberg LE, Fleseriu M (2023) Cushing\u2019s syndrome. Lancet 402(10418):2237\u20132252. https:\/\/doi.org\/10.1016\/S0140-6736(23)01961-X","journal-title":"Lancet"},{"issue":"3","key":"2758_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1530\/EJE-19-0305","volume":"181","author":"K Laugesen","year":"2019","unstructured":"Laugesen K, J\u00f8rgensen JOL, Petersen I, S\u00f8rensen HT (2019) Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark. Eur J Endocrinol 181(3):267\u2013273. https:\/\/doi.org\/10.1530\/EJE-19-0305","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2758_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jama.2023.11305","volume":"330","author":"M Reincke","year":"2023","unstructured":"Reincke M, Fleseriu M, Cushing Syndrome (2023) JAMA 330(2):170. https:\/\/doi.org\/10.1001\/jama.2023.11305","journal-title":"JAMA"},{"issue":"1","key":"2758_CR5","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M et al (2023) European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 189(1):G1\u2013G42. https:\/\/doi.org\/10.1093\/ejendo\/lvad066","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2758_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/cen.14014","volume":"91","author":"S Wengander","year":"2019","unstructured":"Wengander S, Trimpou P, Papakokkinou E, Ragnarsson O (2019) The incidence of endogenous Cushing\u2019s syndrome in the modern era. Clin Endocrinol (Oxf) 91(2):263\u2013270. https:\/\/doi.org\/10.1111\/cen.14014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2758_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11102-014-0569-6","volume":"18","author":"MS Broder","year":"2015","unstructured":"Broder MS, Neary MP, Chang E, Cherepanov D, Ludlam WH (2015) Incidence of Cushing\u2019s syndrome and Cushing\u2019s disease in commercially-insured patients <65 years old in the united States. Pituitary 18(3):283\u2013289. https:\/\/doi.org\/10.1007\/s11102-014-0569-6","journal-title":"Pituitary"},{"issue":"3","key":"2758_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1530\/EJE-11-0272","volume":"165","author":"E Valassi","year":"2011","unstructured":"Valassi E, Santos A, Yaneva M et al (2011) The European Registry on Cushing\u2019s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165(3):383\u2013392. https:\/\/doi.org\/10.1530\/EJE-11-0272","journal-title":"Eur J Endocrinol"},{"key":"2758_CR9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae517","author":"F Ceccato","year":"2024","unstructured":"Ceccato F, Bavaresco A, Ragazzi E et al (2024) Clinical and biochemical data for the diagnosis of endogenous hypercortisolism: the \u201cCushingomic\u201d approach. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae517","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2758_CR10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s11102-022-01222-2","volume":"25","author":"C Scaroni","year":"2022","unstructured":"Scaroni C, Mondin A, Ceccato F (2022) How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing). Pituitary 25(5):701\u2013704. https:\/\/doi.org\/10.1007\/s11102-022-01222-2","journal-title":"Pituitary"},{"issue":"12","key":"2758_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. The Lancet Diabetes & Endocrinology 9(12):847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"5","key":"2758_CR12","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BMK, Findling JW et al (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93(5):1526\u20131540. https:\/\/doi.org\/10.1210\/jc.2008-0125","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2758_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgaa105","volume":"105","author":"BP Galm","year":"2020","unstructured":"Galm BP, Qiao N, Klibanski A, Biller BMK, Tritos NA (2020) Accuracy of laboratory tests for the diagnosis of Cushing syndrome. J Clin Endocrinol Metab 105(6):1\u201314. https:\/\/doi.org\/10.1210\/clinem\/dgaa105","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2758_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-024-02449-5","volume":"48","author":"F Ceccato","year":"2025","unstructured":"Ceccato F, Terzolo M, Scaroni C (2025) Who and how to screen for endogenous hypercortisolism in a high-risk population: a special issue of the journal of endocrinological investigations. J Endocrinol Invest 48(Suppl 1):1\u20132. https:\/\/doi.org\/10.1007\/s40618-024-02449-5","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2758_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA et al (2011) GRADE guidelines: 1. introduction\u2014GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64(4):383\u2013394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026","journal-title":"J Clin Epidemiol"},{"issue":"7650","key":"2758_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924\u2013926. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD","journal-title":"BMJ"},{"issue":"9","key":"2758_CR17","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s40618-023-02058-8","volume":"46","author":"R Pivonello","year":"2023","unstructured":"Pivonello R, Scaroni C, Polistena B, Migliore A, Giustina A (2023) Unmet needs on the current medical management of cushing\u2019s syndrome: results from a Delphi panel of Italian endocrinologists. J Endocrinol Invest 46(9):1923\u20131934. https:\/\/doi.org\/10.1007\/s40618-023-02058-8","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2758_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101519","volume":"35","author":"S Petersenn","year":"2021","unstructured":"Petersenn S (2021) Biochemical diagnosis of Cushing\u2019s disease: screening and confirmatory testing. Best Pract Res Clin Endocrinol Metab 35(1):101519. https:\/\/doi.org\/10.1016\/j.beem.2021.101519","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"12","key":"2758_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1055\/a-2299-5065","volume":"132","author":"I Tizianel","year":"2024","unstructured":"Tizianel I, Barbot M, Ceccato F (2024) Subtyping of cushing\u2019s syndrome: a step ahead. Exp Clin Endocrinol Diabetes 132(12):659\u2013669. https:\/\/doi.org\/10.1055\/a-2299-5065","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2758_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(23)00150-X","author":"E Nowak","year":"2023","unstructured":"Nowak E, Vogel F, Albani A et al (2023) Diagnostic challenges in cyclic Cushing\u2019s syndrome: a systematic review. Lancet Diabetes Endocrinol. https:\/\/doi.org\/10.1016\/S2213-8587(23)00150-X","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2758_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/cen.13758","volume":"89","author":"D Jahandideh","year":"2018","unstructured":"Jahandideh D, Swearingen B, Nachtigall LB, Klibanski A, Biller BMK, Tritos NA (2018) Characterization of cyclic cushing\u2019s disease using late night salivary cortisol testing. Clin Endocrinol (Oxf) 89(3):336\u2013345. https:\/\/doi.org\/10.1111\/cen.13758","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2758_CR22","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1210\/js.2019-00186","volume":"3","author":"H Raff","year":"2019","unstructured":"Raff H, Phillips JM (2019) Bedtime salivary cortisol and cortisone by LC-MS\/MS in healthy adult subjects: evaluation of sampling time. J Endocr Soc 3(8):1631\u20131640. https:\/\/doi.org\/10.1210\/js.2019-00186","journal-title":"J Endocr Soc"},{"issue":"2","key":"2758_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/cen.12259","volume":"80","author":"S Petersenn","year":"2014","unstructured":"Petersenn S, Newell-Price J, Findling JW et al (2014) High variability in baseline urinary free cortisol values in patients with Cushing\u2019s disease. Clin Endocrinol (Oxf) 80(2):261\u2013269. https:\/\/doi.org\/10.1111\/cen.12259","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2758_CR24","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1210\/jc.2009-1500","volume":"94","author":"E Valassi","year":"2009","unstructured":"Valassi E, Swearingen B, Lee H et al (2009) Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in cushing\u2019s syndrome. J Clin Endocrinol Metab 94(12):4851\u20134859. https:\/\/doi.org\/10.1210\/jc.2009-1500","journal-title":"J Clin Endocrinol Metab"},{"key":"2758_CR25","unstructured":"Flockhart DA, Thacker D, McDonald C, Desta Z (2025) the Flockhart Cytochrome P450 Drug-Drug Interaction Table. Division of Clinical Pharmacology, Indiana University School of Medicine (Updated 2021). Accessed January 4. https:\/\/drug-interactions.medicine.iu.edu\/"},{"issue":"8","key":"2758_CR26","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s40618-020-01197-6","volume":"43","author":"F Ceccato","year":"2020","unstructured":"Ceccato F, Artusi C, Barbot M et al (2020) Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation. J Endocrinol Invest 43(8):1105\u20131113. https:\/\/doi.org\/10.1007\/s40618-020-01197-6","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2758_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1210\/er.2016-1105","volume":"38","author":"C Scaroni","year":"2017","unstructured":"Scaroni C, Zilio M, Foti M, Boscaro M (2017) Glucose metabolism abnormalities in Cushing syndrome: from molecular basis to clinical management. Endocr Rev 38(3):189\u2013219. https:\/\/doi.org\/10.1210\/er.2016-1105","journal-title":"Endocr Rev"},{"key":"2758_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02455-7","author":"V Guarnotta","year":"2024","unstructured":"Guarnotta V, Giordano C, Reimondo G (2024) Who and how to screen for endogenous hypercortisolism in type 2 diabetes mellitus or obesity. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-024-02455-7","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2758_CR29","doi-asserted-by":"publisher","first-page":"R247","DOI":"10.1530\/EJE-16-0434","volume":"175","author":"C Steffensen","year":"2016","unstructured":"Steffensen C, Pereira AM, Dekkers OM, J\u00f8rgensen JOL (2016) Diagnosis of endocrine disease: prevalence of hypercortisolism in type 2 diabetes patients: a systematic review and meta-analysis. Eur J Endocrinol 175(6):R247\u2013R253. https:\/\/doi.org\/10.1530\/EJE-16-0434","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2758_CR30","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.eprac.2021.07.014","volume":"27","author":"C Aresta","year":"2021","unstructured":"Aresta C, Soranna D, Giovanelli L et al (2021) When to suspect hidden hypercortisolism in type 2 diabetes: a meta-analysis. Endocr Pract 27(12):1216\u20131224. https:\/\/doi.org\/10.1016\/j.eprac.2021.07.014","journal-title":"Endocr Pract"},{"key":"2758_CR31","doi-asserted-by":"publisher","unstructured":"Buse JB, Kahn SE, Aroda VR et al (2025) Prevalence of hypercortisolism in Difficult-to-Control type 2 diabetes. Diabetes Care (Published Online April 18). https:\/\/doi.org\/10.2337\/dc24-2841","DOI":"10.2337\/dc24-2841"},{"issue":"2","key":"2758_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-2265.2007.02865.x","volume":"67","author":"G Reimondo","year":"2007","unstructured":"Reimondo G, Pia A, Allasino B et al (2007) Screening of Cushing\u2019s syndrome in adult patients with newly diagnosed diabetes mellitus. Clin Endocrinol (Oxf) 67(2):225\u2013229. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02865.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2758_CR33","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EC-19-0435","volume":"9","author":"C Scaroni","year":"2020","unstructured":"Scaroni C, Albiger NM, Palmieri S et al (2020) Approach to patients with pseudo-Cushing\u2019s states. Endocr Connect 9(1):R1\u2013R13. https:\/\/doi.org\/10.1530\/EC-19-0435","journal-title":"Endocr Connect"},{"issue":"2","key":"2758_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/cen.13071","volume":"85","author":"C Steffensen","year":"2016","unstructured":"Steffensen C, Thomsen HH, Dekkers OM, Christiansen JS, Rungby J, J\u00f8rgensen JOL (2016) Low positive predictive value of midnight salivary cortisol measurement to detect hypercortisolism in type 2 diabetes. Clin Endocrinol (Oxf) 85(2):202\u2013206. https:\/\/doi.org\/10.1111\/cen.13071","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2758_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40618-018-0921-1","volume":"42","author":"F Ceccato","year":"2019","unstructured":"Ceccato F, Marcelli G, Martino M et al (2019) The diagnostic accuracy of increased late night salivary cortisol for Cushing\u2019s syndrome: a real-life prospective study. J Endocrinol Invest 42(3):327\u2013335. https:\/\/doi.org\/10.1007\/s40618-018-0921-1","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2758_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH et al (2025) Definition and diagnostic criteria of clinical obesity. The Lancet Diabetes & Endocrinology 13(3):221\u2013262. https:\/\/doi.org\/10.1016\/S2213-8587(24)00316-4","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"10481","key":"2758_CR37","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","volume":"405","author":"M Ng","year":"2025","unstructured":"Ng M, Gakidou E, Lo J et al (2025) Global, regional, and National prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the global burden of disease study 2021. Lancet 405(10481):813\u2013838. https:\/\/doi.org\/10.1016\/S0140-6736(25)00355-1","journal-title":"Lancet"},{"issue":"1","key":"2758_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-19-0666","volume":"182","author":"LT van Hulsteijn","year":"2020","unstructured":"van Hulsteijn LT, Pasquali R, Casanueva F et al (2020) Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis. Eur J Endocrinol 182(1):11\u201321. https:\/\/doi.org\/10.1530\/EJE-19-0666","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2758_CR39","doi-asserted-by":"publisher","first-page":"e3723","DOI":"10.1210\/clinem\/dgac379","volume":"107","author":"LT Braun","year":"2022","unstructured":"Braun LT, Vogel F, Zopp S et al (2022) Whom should we screen for Cushing syndrome? The Endocrine Society Practice Guideline Recommendations 2008 revisited. J Clin Endocrinol Metab 107(9):e3723\u2013e3730. https:\/\/doi.org\/10.1210\/clinem\/dgac379","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2758_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00563-5","volume":"10","author":"IJ Neeland","year":"2024","unstructured":"Neeland IJ, Lim S, Tchernof A et al (2024) Metabolic syndrome. Nat Rev Dis Primers 10(1):77. https:\/\/doi.org\/10.1038\/s41572-024-00563-5","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"2758_CR41","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1590\/s0004-27302007000800025","volume":"51","author":"R Pivonello","year":"2007","unstructured":"Pivonello R, De Martino MC, De Leo M et al (2007) Cushing\u2019s syndrome: aftermath of the cure. Arq Bras Endocrinol Metabol 51(8):1381\u20131391. https:\/\/doi.org\/10.1590\/s0004-27302007000800025","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"2","key":"2758_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/cen.14129","volume":"92","author":"S Jha","year":"2020","unstructured":"Jha S, Sinaii N, McGlotten RN, Nieman LK (2020) Remission of hypertension after surgical cure of Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 92(2):124\u2013130. https:\/\/doi.org\/10.1111\/cen.14129","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2758_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00321","volume":"10","author":"M Barbot","year":"2019","unstructured":"Barbot M, Ceccato F, Scaroni C (2019) The pathophysiology and treatment of hypertension in patients with Cushing\u2019s syndrome. Front Endocrinol (Lausanne) 10:321. https:\/\/doi.org\/10.3389\/fendo.2019.00321","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2758_CR44","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/cen.13391","volume":"87","author":"F Ceccato","year":"2017","unstructured":"Ceccato F, Trementino L, Barbot M et al (2017) Diagnostic accuracy of increased urinary cortisol\/cortisone ratio to differentiate ACTH-dependent cushing\u2019s syndrome. Clin Endocrinol (Oxf) 87(5):500\u2013507. https:\/\/doi.org\/10.1111\/cen.13391","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2758_CR45","doi-asserted-by":"publisher","unstructured":"Martino MCD, Canu L, Bonaventura I, Vitiello C, Sparano C, Cozzolino A (2025) Hypertension and cushing\u2019s syndrome: Hunt for the red flag. J Endocrinol Invest (Published Online March 18). https:\/\/doi.org\/10.1007\/s40618-024-02453-9","DOI":"10.1007\/s40618-024-02453-9"},{"key":"2758_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02453-9","author":"MCD Martino","year":"2025","unstructured":"Martino MCD, Canu L, Bonaventura I, Vitiello C, Sparano C, Cozzolino A (2025) Hypertension and cushing\u2019s syndrome: Hunt for the red flag. J Endocrinol Invest Published Online March. https:\/\/doi.org\/10.1007\/s40618-024-02453-9","journal-title":"J Endocrinol Invest Published Online March"},{"issue":"5","key":"2758_CR47","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/00004872-199405000-00015","volume":"12","author":"GH Anderson","year":"1994","unstructured":"Anderson GH, Blakeman N, Streeten DHP (1994) The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 12(5):609. https:\/\/doi.org\/10.1097\/00004872-199405000-00015","journal-title":"J Hypertens"},{"issue":"1\u20136","key":"2758_CR48","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.0954-6820.1981.tb11628.x","volume":"209","author":"M Danielson","year":"1981","unstructured":"Danielson M, Dammstr\u00f6m B (1981) The prevalence of secondary and curable hypertension. Acta Med Scand 209(1\u20136):451\u2013455. https:\/\/doi.org\/10.1111\/j.0954-6820.1981.tb11628.x","journal-title":"Acta Med Scand"},{"issue":"2","key":"2758_CR49","first-page":"108","volume":"8","author":"R Trifanescu","year":"2013","unstructured":"Trifanescu R, Carsote M, Caragheorgheopol A et al (2013) Screening for secondary endocrine hypertension in young patients. Maedica (Buchar) 8(2):108\u2013115. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24371473","journal-title":"Maedica (Buchar)"},{"issue":"6","key":"2758_CR50","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1507\/endocrj.EJ19-0262","volume":"67","author":"M Aoe","year":"2020","unstructured":"Aoe M, Okada A, Usui T, Manaka K, Nangaku M, Makita N (2020) Comparison between the clinical characteristics of patients with adrenal incidentalomas and those with hypertension-associated adrenal tumors in a single center in Japan. Endocr J 67(6):645\u2013654. https:\/\/doi.org\/10.1507\/endocrj.EJ19-0262","journal-title":"Endocr J"},{"key":"2758_CR51","doi-asserted-by":"publisher","DOI":"10.1080\/08037051.2023.2224898","author":"I Sudano","year":"2023","unstructured":"Sudano I, Suter P, Beuschlein F (2023) Secondary hypertension as a cause of treatment resistance. Blood Press. https:\/\/doi.org\/10.1080\/08037051.2023.2224898","journal-title":"Blood Press"},{"issue":"12","key":"2758_CR52","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M et al (2023) 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European society of hypertension. J Hypertens 41(12):1874\u20132071. https:\/\/doi.org\/10.1097\/HJH.0000000000003480","journal-title":"J Hypertens"},{"issue":"2","key":"2758_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40292-020-00367-0","volume":"27","author":"RM Bruno","year":"2020","unstructured":"Bruno RM, Taddei S, Borghi C et al (2020) Italian society of arterial hypertension (SIIA) position paper on the role of renal denervation in the management of the Difficult-to-Treat hypertensive patient. High Blood Press Cardiovasc Prev 27(2):109\u2013117. https:\/\/doi.org\/10.1007\/s40292-020-00367-0","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"3","key":"2758_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1291\/hypres.27.193","volume":"27","author":"M Omura","year":"2004","unstructured":"Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27(3):193\u2013202. https:\/\/doi.org\/10.1291\/hypres.27.193","journal-title":"Hypertens Res"},{"issue":"5","key":"2758_CR55","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1097\/HJH.0b013e3283521484","volume":"30","author":"LC Martins","year":"2012","unstructured":"Martins LC, Concei\u00e7\u00e3o FL, Muxfeldt ES, Salles GF (2012) Prevalence and associated factors of subclinical hypercortisolism in patients with resistant hypertension. J Hypertens 30(5):967\u2013973. https:\/\/doi.org\/10.1097\/HJH.0b013e3283521484","journal-title":"J Hypertens"},{"issue":"4","key":"2758_CR56","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1373\/clinchem.2003.029934","volume":"50","author":"KCA Chan","year":"2004","unstructured":"Chan KCA, Lit LCW, Law ELK et al (2004) Diminished urinary free cortisol excretion in patients with moderate and severe renal impairment. Clin Chem 50(4):757\u2013759. https:\/\/doi.org\/10.1373\/clinchem.2003.029934","journal-title":"Clin Chem"},{"issue":"5","key":"2758_CR57","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11102-022-01249-5","volume":"25","author":"S Petersenn","year":"2022","unstructured":"Petersenn S (2022) Overnight 1\u00a0mg dexamethasone suppression test and 24\u00a0h urine free cortisol\u2014accuracy and pitfalls when screening for cushing\u2019s syndrome. Pituitary 25(5):693\u2013697. https:\/\/doi.org\/10.1007\/s11102-022-01249-5","journal-title":"Pituitary"},{"issue":"6","key":"2758_CR58","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1373\/clinchem.2004.032243","volume":"50","author":"M Fenske","year":"2004","unstructured":"Fenske M (2004) How much urinary free cortisol is really cortisol during water diuresis in healthy individuals? Clin Chem 50(6):1102\u20131104. https:\/\/doi.org\/10.1373\/clinchem.2004.032243","journal-title":"Clin Chem"},{"issue":"3","key":"2758_CR59","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11906-021-01131-y","volume":"23","author":"MA Fravel","year":"2021","unstructured":"Fravel MA, Ernst M (2021) Drug interactions with antihypertensives. Curr Hypertens Rep 23(3):14. https:\/\/doi.org\/10.1007\/s11906-021-01131-y","journal-title":"Curr Hypertens Rep"},{"key":"2758_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02452-w","author":"L Chioma","year":"2024","unstructured":"Chioma L, Patti G, Cappa M, Maghnie M (2024) Cushing syndrome in paediatric population: who and how to screen. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-024-02452-w","journal-title":"J Endocrinol Invest"},{"key":"2758_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1345174","author":"MO Savage","year":"2024","unstructured":"Savage MO, Ferrigno R (2024) Paediatric Cushing\u2019s disease: long-term outcome and predictors of recurrence. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2024.1345174","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2758_CR62","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/ejendo\/lvae114","volume":"191","author":"C Padilla","year":"2024","unstructured":"Padilla C, Stratakis CA, Tatsi C (2024) The phenotype of the pediatric patient with Cushing syndrome but without obesity. Eur J Endocrinol 191(4):399\u2013406. https:\/\/doi.org\/10.1093\/ejendo\/lvae114","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2758_CR63","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ando.2024.01.005","volume":"85","author":"L Martinerie","year":"2024","unstructured":"Martinerie L, Bouligand J, North MO, Bertherat J, Assi\u00e9 G, Espiard S (2024) Consensus statement by the French society of endocrinology (SFE) and French society of pediatric endocrinology & diabetology (SFEDP) for the diagnosis of cushing\u2019s syndrome: genetics of cushing\u2019s syndrome. Ann Endocrinol (Paris) 85(4):284\u2013293. https:\/\/doi.org\/10.1016\/j.ando.2024.01.005","journal-title":"Ann Endocrinol (Paris)"},{"key":"2758_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1383318","author":"LT Fourman","year":"2024","unstructured":"Fourman LT, Lima JG, Simha V et al (2024) A rapid action plan to improve diagnosis and management of lipodystrophy syndromes. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2024.1383318","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2758_CR65","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1177\/1099800413507128","volume":"16","author":"PD Tryphonopoulos","year":"2014","unstructured":"Tryphonopoulos PD, Letourneau N, Azar R (2014) Approaches to salivary cortisol collection and analysis in infants. Biol Res Nurs 16(4):398\u2013408. https:\/\/doi.org\/10.1177\/1099800413507128","journal-title":"Biol Res Nurs"},{"key":"2758_CR66","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae590","author":"L Kervezee","year":"2024","unstructured":"Kervezee L, Romijn M, van de Weijer KNG et al (2024) Development of 24-hour rhythms in cortisol secretion across infancy: a systematic review and meta-analysis of individual participant data. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae590","journal-title":"J Clin Endocrinol Metab"},{"key":"2758_CR67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000494904","volume":"53","author":"G Arnaldi","year":"2019","unstructured":"Arnaldi G, Martino M (2019) Androgens in cushing\u2019s syndrome. Front Horm Res 53:77\u201391. https:\/\/doi.org\/10.1159\/000494904","journal-title":"Front Horm Res"},{"issue":"4","key":"2758_CR68","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.1365-2265.2000.01117.x","volume":"53","author":"GA Kaltsas","year":"2000","unstructured":"Kaltsas GA, Korbonits M, Isidori AM et al (2000) How common are polycystic ovaries and the polycystic ovarian syndrome in women with cushing\u2019s syndrome? Clin Endocrinol (Oxf) 53(4):493\u2013500. https:\/\/doi.org\/10.1046\/j.1365-2265.2000.01117.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2758_CR69","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s11102-022-01292-2","volume":"26","author":"A Akirov","year":"2023","unstructured":"Akirov A, Dery L, Fleseriu M et al (2023) Cushing\u2019s syndrome in women: age-related differences in etiology and clinical picture. Pituitary 26(1):144\u2013151. https:\/\/doi.org\/10.1007\/s11102-022-01292-2","journal-title":"Pituitary"},{"key":"2758_CR70","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-025-02537-0","author":"F Ferra\u00f9","year":"2025","unstructured":"Ferra\u00f9 F, Alessi Y, Nista F, Roux A, Ferone D, Arvat E (2025) Who and how to screen for endogenous hypercortisolism among young women presenting with clinical hyperandrogenism and\/or menstrual abnormalities. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-025-02537-0","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2758_CR71","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/09513590400027190","volume":"20","author":"Z Penezi\u0107","year":"2005","unstructured":"Penezi\u0107 Z, \u017darkovi\u0107 M, Vujovi\u0107 S et al (2005) Gonadotropin pulsatility in cushing\u2019s syndrome compared with polycystic ovary syndrome. Gynecol Endocrinol 20(3):150\u2013154. https:\/\/doi.org\/10.1080\/09513590400027190","journal-title":"Gynecol Endocrinol"},{"key":"2758_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02454-8","author":"M Barbot","year":"2024","unstructured":"Barbot M, Lazzara M, Mazzeo P, Pecori Giraldi F (2024) Unusual infections and thrombotic events in Cushing\u2019s syndrome. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-024-02454-8","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2758_CR73","first-page":"158","volume":"74","author":"M Vastbinder","year":"2016","unstructured":"Vastbinder M, Kuindersma M, Mulder AH, Schuijt MP, Mudde AH (2016) The influence of oral contraceptives on overnight 1\u00a0mg dexamethasone suppression test. Neth J Med 74(4):158\u2013161. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27185774","journal-title":"Neth J Med"},{"issue":"4","key":"2758_CR74","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1210\/er.2018-00005","volume":"39","author":"G Mazziotti","year":"2018","unstructured":"Mazziotti G, Frara S, Giustina A (2018) Pituitary diseases and bone. Endocr Rev 39(4):440\u2013488. https:\/\/doi.org\/10.1210\/er.2018-00005","journal-title":"Endocr Rev"},{"issue":"10","key":"2758_CR75","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","volume":"18","author":"E Canalis","year":"2007","unstructured":"Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18(10):1319\u20131328. https:\/\/doi.org\/10.1007\/s00198-007-0394-0","journal-title":"Osteoporos Int"},{"key":"2758_CR76","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12299","author":"M Zilio","year":"2014","unstructured":"Zilio M, Barbot M, Ceccato F et al (2014) Diagnosis and complications of Cushing\u2019s disease: gender-related differences. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.12299","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2758_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02450-y","author":"R Giordano","year":"2024","unstructured":"Giordano R, Parasiliti Caprino M, Loli P, Giustina A (2024) Screening for endogenous hypercortisolism in patients with osteoporosis and fractures: why, when and how. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-024-02450-y","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"2758_CR78","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BMK, Colao A (2016) Complications of cushing\u2019s syndrome: state of the Art. Lancet Diabetes Endocrinol 4(7):611\u2013629. https:\/\/doi.org\/10.1016\/S2213-8587(16)00086-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2758_CR79","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00198-013-2520-5","volume":"25","author":"L Trementino","year":"2014","unstructured":"Trementino L, Appolloni G, Ceccoli L et al (2014) Bone complications in patients with cushing\u2019s syndrome: looking for clinical, biochemical, and genetic determinants. Osteoporos Int 25(3):913\u2013921. https:\/\/doi.org\/10.1007\/s00198-013-2520-5","journal-title":"Osteoporos Int"},{"issue":"1","key":"2758_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-015-0244-1","volume":"10","author":"ZE Belaya","year":"2015","unstructured":"Belaya ZE, Hans D, Rozhinskaya LY et al (2015) The risk factors for fractures and trabecular bone-score value in patients with endogenous cushing\u2019s syndrome. Arch Osteoporos 10(1):1\u20139. https:\/\/doi.org\/10.1007\/s11657-015-0244-1","journal-title":"Arch Osteoporos"},{"issue":"2","key":"2758_CR81","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12020-023-03318-6","volume":"80","author":"F Ferra\u00f9","year":"2023","unstructured":"Ferra\u00f9 F, Giovinazzo S, Alessi Y et al (2023) Trabecular bone score, bone marrow fat and vertebral fractures in Cushing syndrome. Endocrine 80(2):441\u2013447. https:\/\/doi.org\/10.1007\/s12020-023-03318-6","journal-title":"Endocrine"},{"issue":"4","key":"2758_CR82","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tem.2023.01.006","volume":"34","author":"MM Uygur","year":"2023","unstructured":"Uygur MM, Frara S, di Filippo L, Giustina A (2023) New tools for bone health assessment in secreting pituitary adenomas. Trends Endocrinol Metab 34(4):231\u2013242. https:\/\/doi.org\/10.1016\/j.tem.2023.01.006","journal-title":"Trends Endocrinol Metab"},{"issue":"12","key":"2758_CR83","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1055\/a-2329-5787","volume":"132","author":"G Zavatta","year":"2024","unstructured":"Zavatta G, Di Dalmazi G (2024) Mild autonomous cortisol secretion (MACS) \u2013 related osteoporosis. Exp Clin Endocrinol Diabetes 132(12):712\u2013722. https:\/\/doi.org\/10.1055\/a-2329-5787","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2758_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00129","author":"R Pivonello","year":"2015","unstructured":"Pivonello R, Simeoli C, De Martino MC et al (2015) Neuropsychiatric disorders in cushing\u2019s syndrome. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2015.00129","journal-title":"Front Neurosci"},{"issue":"8","key":"2758_CR85","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40265-017-0735-z","volume":"77","author":"A Santos","year":"2017","unstructured":"Santos A, Resmini E, Pascual JC, Crespo I, Webb SM (2017) Psychiatric symptoms in patients with cushing\u2019s syndrome: prevalence, diagnosis and management. Drugs 77(8):829\u2013842. https:\/\/doi.org\/10.1007\/s40265-017-0735-z","journal-title":"Drugs"},{"issue":"3","key":"2758_CR86","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ecl.2013.05.010","volume":"42","author":"MN Starkman","year":"2013","unstructured":"Starkman MN (2013) Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration. Endocrinol Metab Clin North Am 42(3):477\u2013488. https:\/\/doi.org\/10.1016\/j.ecl.2013.05.010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2758_CR87","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02457-5","author":"E Ferrante","year":"2024","unstructured":"Ferrante E, Simeoli C, Mantovani G, Pivonello R (2024) Who and how to screen for endogenous hypercortisolism in patients with mood disorders. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-024-02457-5","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2758_CR88","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.biopsych.2005.10.014","volume":"60","author":"J Keller","year":"2006","unstructured":"Keller J, Flores B, Gomez RG et al (2006) Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry 60(3):275\u2013281. https:\/\/doi.org\/10.1016\/j.biopsych.2005.10.014","journal-title":"Biol Psychiatry"},{"issue":"6","key":"2758_CR89","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1530\/EJE-17-0078","volume":"176","author":"G\u00c5 Ueland","year":"2017","unstructured":"Ueland G\u00c5, Methlie P, Kellmann R et al (2017) Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test. Eur J Endocrinol 176(6):705\u2013713. https:\/\/doi.org\/10.1530\/EJE-17-0078","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2758_CR90","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/01.ALC.0000071738.53337.F4","volume":"27","author":"DE Feierman","year":"2003","unstructured":"Feierman DE, Melinkov Z, Nanji AA (2003) Induction of CYP3A by ethanol in multiple in vitro and in vivo models. Alcohol Clin Exp Res 27(6):981\u2013988. https:\/\/doi.org\/10.1097\/01.ALC.0000071738.53337.F4","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"2758_CR91","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1530\/EJE-13-0702","volume":"170","author":"RA Alwani","year":"2014","unstructured":"Alwani RA, Schmit Jongbloed LW, de Jong FH, van der Lely AJ, de Herder WW, Feelders RA (2014) Differentiating between cushing\u2019s disease and pseudo-Cushing\u2019s syndrome: comparison of four tests. Eur J Endocrinol 170(4):477. https:\/\/doi.org\/10.1530\/EJE-13-0702","journal-title":"Eur J Endocrinol"},{"issue":"17","key":"2758_CR92","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1001\/jama.1993.03500170062035","volume":"269","author":"JA Yanovski","year":"1993","unstructured":"Yanovski JA, Cutler GB, Chrousos GP, Nieman LK (1993) Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish cushing\u2019s syndrome from pseudo-Cushing\u2019s States. JAMA 269(17):2232\u20132238. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8386285","journal-title":"JAMA"},{"issue":"10","key":"2758_CR93","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s40618-023-02099-z","volume":"46","author":"A Mondin","year":"2023","unstructured":"Mondin A, Barbot M, Voltan G et al (2023) Second-line tests in the differential diagnosis of neoplastic and non-neoplastic hypercortisolism: a systematic review and meta-analysis. J Endocrinol Invest 46(10):1947\u20131959. https:\/\/doi.org\/10.1007\/s40618-023-02099-z","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"2758_CR94","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s40618-023-02113-4","volume":"46","author":"F Ceccato","year":"2023","unstructured":"Ceccato F, Di Dalmazi G (2023) Shortage of hCRH for the diagnosis of endogenous CS: the end of an era or the beginning of a new journey? J Endocrinol Invest 46(10):2189\u20132191. https:\/\/doi.org\/10.1007\/s40618-023-02113-4","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2758_CR95","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1093\/ejendo\/lvae073","volume":"191","author":"A Colao","year":"2024","unstructured":"Colao A, Scaroni C, Mez\u00f6si E et al (2024) Diagnostic work-up of ACTH-dependent cushing\u2019s syndrome in the context of CRH shortage: recommendation of a task force from the European society of endocrinology. Eur J Endocrinol 191(1):R32\u2013R35. https:\/\/doi.org\/10.1093\/ejendo\/lvae073","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2758_CR96","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s40618-021-01615-3","volume":"44","author":"F Ceccato","year":"2021","unstructured":"Ceccato F, Barbot M, Scaroni C, Boscaro M (2021) Frequently asked questions and answers (if any) in patients with adrenal incidentaloma. J Endocrinol Invest 44(12):2749\u20132763. https:\/\/doi.org\/10.1007\/s40618-021-01615-3","journal-title":"J Endocrinol Invest"},{"key":"2758_CR97","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02456-6","author":"K Coscia","year":"2024","unstructured":"Coscia K, Verrienti M, Di Dalmazi G, Zatelli MC (2024) Who and how to screen for endogenous hypercortisolism in adrenal and pituitary incidentaloma. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-024-02456-6","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"2758_CR98","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","volume":"10","author":"T Deutschbein","year":"2022","unstructured":"Deutschbein T, Reimondo G, Di Dalmazi G et al (2022) Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Lancet Diabetes Endocrinol 10(7):499\u2013508. https:\/\/doi.org\/10.1016\/S2213-8587(22)00100-0","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2758_CR99","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/ejendo\/lvad038","volume":"188","author":"G Zavatta","year":"2023","unstructured":"Zavatta G, Vicennati V, Altieri P et al (2023) Mild autonomous cortisol secretion in adrenal incidentalomas and risk of fragility fractures: a large cross-sectional study. Eur J Endocrinol 188(4):343\u2013352. https:\/\/doi.org\/10.1093\/ejendo\/lvad038","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2758_CR100","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1093\/ejendo\/lvad134","volume":"189","author":"ICM Pelsma","year":"2023","unstructured":"Pelsma ICM, Fassnacht M, Tsagarakis S et al (2023) Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis. Eur J Endocrinol 189(4):S88\u2013S101. https:\/\/doi.org\/10.1093\/ejendo\/lvad134","journal-title":"Eur J Endocrinol"},{"key":"2758_CR101","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0644-8","author":"F Ceccato","year":"2017","unstructured":"Ceccato F, Antonelli G, Frigo AC (2017) First-line screening tests for Cushing\u2019s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS\/MS. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-017-0644-8","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2758_CR102","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1530\/EJE-14-0599","volume":"172","author":"A Toini","year":"2015","unstructured":"Toini A, Dolci A, Ferrante E et al (2015) Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma. Eur J Endocrinol 172(4):363\u2013369. https:\/\/doi.org\/10.1530\/EJE-14-0599","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2758_CR103","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1507\/endocrj.EJ15-0446","volume":"63","author":"D Tamada","year":"2016","unstructured":"Tamada D, Kitamura T, Otsuki M, Oshino S, Saitoh Y, Shimomura I (2016) Clinical significance of screening for subclinical cushing\u2019s disease in patients with pituitary tumors. Endocr J 63(1):47\u201352. https:\/\/doi.org\/10.1507\/endocrj.EJ15-0446","journal-title":"Endocr J"},{"key":"2758_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-025-01134-8","author":"M Fleseriu","year":"2025","unstructured":"Fleseriu M, Gurnell M, McCormack A (2025) Pituitary incidentaloma: a Pituitary Society international consensus guideline statement. Nat Rev Endocrinol. https:\/\/doi.org\/10.1038\/s41574-025-01134-8","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2758_CR105","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1530\/EJE-13-0320","volume":"169","author":"M Yaneva","year":"2013","unstructured":"Yaneva M, Kalinov K, Zacharieva S (2013) Mortality in cushing\u2019s syndrome: data from 386 patients from a single tertiary referral center. Eur J Endocrinol 169(5):621\u2013627. https:\/\/doi.org\/10.1530\/EJE-13-0320","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2758_CR106","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/jc.2012-3582","volume":"98","author":"OM Dekkers","year":"2013","unstructured":"Dekkers OM, Horv\u00e1th-Puh\u00f3 E, J\u00f8rgensen JOL et al (2013) Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study. J Clin Endocrinol Metab 98(6):2277\u20132284. https:\/\/doi.org\/10.1210\/jc.2012-3582","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2758_CR107","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1530\/EJE-19-0464","volume":"181","author":"E Valassi","year":"2019","unstructured":"Valassi E, Tabarin A, Brue T et al (2019) High mortality within 90 days of diagnosis in patients with Cushing\u2019s syndrome: results from the ERCUSYN Registry. Eur J Endocrinol 181(5):461\u2013472. https:\/\/doi.org\/10.1530\/EJE-19-0464","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2758_CR108","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s12020-015-0676-9","volume":"50","author":"F Pecori Giraldi","year":"2015","unstructured":"Pecori Giraldi F, Ambrogio AG (2015) Variability in laboratory parameters used for management of Cushing\u2019s syndrome. Endocrine 50(3):580\u2013589. https:\/\/doi.org\/10.1007\/s12020-015-0676-9","journal-title":"Endocrine"},{"key":"2758_CR109","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01384-5","author":"F Ferra\u00f9","year":"2020","unstructured":"Ferra\u00f9 F, Ceccato F, Cannav\u00f2 S, Scaroni C (2020) What we have to know about corticosteroids use during Sars-Cov-2 infection. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-020-01384-5","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2758_CR110","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12020-009-9186-y","volume":"36","author":"D Kastelan","year":"2009","unstructured":"Kastelan D, Dusek T, Kraljevic I et al (2009) Hypercoagulability in Cushing\u2019s syndrome: the role of specific haemostatic and fibrinolytic markers. Endocrine 36(1):70\u201374. https:\/\/doi.org\/10.1007\/s12020-009-9186-y","journal-title":"Endocrine"},{"key":"2758_CR111","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvz033","author":"MG Suarez","year":"2020","unstructured":"Suarez MG, Stack M, Hinojosa-Amaya JM (2020) Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study. J Endocr Soc. https:\/\/doi.org\/10.1210\/jendso\/bvz033","journal-title":"J Endocr Soc"},{"issue":"6","key":"2758_CR112","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1210\/jc.2018-02524","volume":"104","author":"O Ragnarsson","year":"2019","unstructured":"Ragnarsson O, Olsson DS, Papakokkinou E et al (2019) Overall and disease-specific mortality in patients with Cushing disease: a Swedish nationwide study. J Clin Endocrinol Metab 104(6):2375\u20132384. https:\/\/doi.org\/10.1210\/jc.2018-02524","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2758_CR113","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11102-015-0634-9","volume":"18","author":"I Shimon","year":"2015","unstructured":"Shimon I (2015) Screening for Cushing\u2019s syndrome: is it worthwhile? Pituitary 18(2):201\u2013205. https:\/\/doi.org\/10.1007\/s11102-015-0634-9","journal-title":"Pituitary"},{"issue":"4","key":"2758_CR114","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/er.2013-1048","volume":"36","author":"R Pivonello","year":"2015","unstructured":"Pivonello R, De Leo M, Cozzolino A, Colao A (2015) The treatment of Cushing\u2019s disease. Endocr Rev 36(4):385\u2013486. https:\/\/doi.org\/10.1210\/er.2013-1048","journal-title":"Endocr Rev"},{"key":"2758_CR115","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-025-02572-x","author":"I Tizianel","year":"2025","unstructured":"Tizianel I, Lizzul L, Mondin A (2025) Cardiometabolic complications after Cushing\u2019s disease remission. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-025-02572-x","journal-title":"J Endocrinol Invest"},{"key":"2758_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.747549","author":"M Parasiliti-Caprino","year":"2021","unstructured":"Parasiliti-Caprino M, Bioletto F, Frigerio T (2021) A new clinical model to estimate the pre-test probability of Cushing\u2019s syndrome: the Cushing score. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2021.747549","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"2758_CR117","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1210\/jc.2016-1673","volume":"101","author":"A Le\u00f3n-Justel","year":"2016","unstructured":"Le\u00f3n-Justel A, Madrazo-Atutxa A, Alvarez-Rios AI et al (2016) A probabilistic model for Cushing\u2019s syndrome screening in at-risk populations: a prospective multicenter study. J Clin Endocrinol Metab 101(10):3747\u20133754. https:\/\/doi.org\/10.1210\/jc.2016-1673","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2758_CR118","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/ejendo\/lvac016","volume":"188","author":"LT Braun","year":"2023","unstructured":"Braun LT, Vogel F, Rubinstein G et al (2023) Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validation. Eur J Endocrinol 188(1):59\u201366. https:\/\/doi.org\/10.1093\/ejendo\/lvac016","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02758-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02758-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02758-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:17:28Z","timestamp":1774415848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02758-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":118,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["2758"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02758-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}